bioXXmed AG reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 0.012233 million compared to EUR 0.044626 million a year ago. Net loss was EUR 0.829837 million compared to EUR 4.06 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.52 EUR | -7.14% |
|
+2.97% | +16.59% |
2023 | BioXXmed AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | BioXXmed AG Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
1st Jan change | Capi. | |
---|---|---|
+16.59% | 2.87M | |
+34.01% | 51.07B | |
-8.02% | 38.78B | |
+34.46% | 38.61B | |
-8.98% | 27.32B | |
+12.56% | 26.35B | |
-19.62% | 19.46B | |
+39.18% | 13.58B | |
+31.47% | 12.46B | |
-3.40% | 11.75B |
- Stock Market
- Equities
- T5O Stock
- News bioXXmed AG
- BioXXmed AG Reports Earnings Results for the Full Year Ended December 31, 2022